Join
Live feed
·
INSIDERFilingvia Quantisnow
bluebird bio Inc. logo

President and CEO Obenshain Andrew sold $636 worth of shares (86 units at $7.39), decreasing direct ownership by 0.46% to 18,485 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
BLUE· bluebird bio Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BLUE (bluebird bio Inc.) and more on Quantisnow.